Green synthesised silver nanoparticles (AgNPs) have been identified as a promising new therapy pathway for cancer because of their anti-angiogenic potency. In the present study, CM-AgNPs were biosynthesized using aqueous leaf extract of Cassia marginata Roxb (CM) and were confirmed by spectral studies like UV-Visible and attenuated total reflection-Fourier transform infrared (ATR-FTIR) spectroscopic techniques. The structure and shape of the biosynthesized CM-AgNPs were confirmed by scanning electron microscope (SEM), energy-dispersive spectroscopy (EDX), and high-resolution transmission electron microscopy (HR-TEM) with selected area electron diffraction (SAED) studies. The antioxidant activity of the synthesized nanoparticles were evaluated by 1,1-diphenyl-2-picrylhydrazyl (DPPH) and ferric reducing antioxidant power (FRAP) assay methods, and the IC values were found to be 19.58 ± 1.62 and 742.33 ± 14.57 µg, respectively. The anticancer activity of CM-AgNPs was evaluated against human breast cancer cell lines MCF-7 and MDA-MB-231 by 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assay, and the IC values were found to be 21.02 ± 1.67 and 26.21 ± 0.33 μg/ml, respectively. These results provide promising information about the biosynthesized CM-AgNPs that can be used in the development of novel anticancer drugs.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s12010-022-04188-w | DOI Listing |
Vaccines (Basel)
December 2024
Department of Chemistry and Biochemistry and School of Green Chemistry and Engineering, University of Toledo, 2801 West Bancroft Street, Toledo, OH 43606, USA.
Background/objectives: The MHCII-dependent, CD4+ T-cell zwitterionic polysaccharide PS A1 has been investigated as a promising carrier for vaccine development because it can induce an MHCII-dependent CD4+ response towards a variety of tumor-associated carbohydrate antigens (TACAs). However, PS A1 cannot elicit cytotoxic T lymphocytes through MHCI, which may or may not hamper its potential clinical use in cancer, infectious and viral vaccine development. This paper addresses PS A1 MHCI independence through the introduction of an MHCI epitope, the poliovirus (PV) peptide, to establish an MHCI- and MHCII-dependent vaccine.
View Article and Find Full Text PDFPolymers (Basel)
December 2024
Green and Sustainable Materials R&D Department, Korea Institute of Industrial Technology (KITECH), Cheonan 31056, Republic of Korea.
Recent advancements in polymer materials have enabled the synthesis of bio-based monomers from renewable resources, promoting sustainable alternatives to fossil-based materials. This study presents a novel zwitterionic surfactant, SF, derived from 10-undecenoic acid obtained from castor oil through a four-step reaction, achieving a yield of 78%. SF has a critical micelle concentration (CMC) of 1235 mg/L, slightly higher than the commercial anionic surfactant Rhodacal DS-4 (sodium dodecyl benzene sulfonate), and effectively stabilizes monomer droplets, leading to excellent conversion and stable latex formation.
View Article and Find Full Text PDFPolymers (Basel)
December 2024
Tecnologico de Monterrey, School of Engineering and Sciences, Atizapan de Zaragoza C.P. 52926, Estado de Mexico, Mexico.
A trend has been established concerning the research and development of various green and biodegradable plastics for multi-purpose applications, aiming to replace petroleum-based plastics. Herein, we report the synthesis of chitosan (CH) films using lemon juice; these were reinforced with NiZnFeO nanoparticles (NiZnFeO NPs) to obtain improved mechanical and barrier properties, facilitating their future application as sustainable, corrosion-resistant coatings for medical instruments. The synthesized NiZnFeO NPs had a crystallite size of ~29 nm.
View Article and Find Full Text PDFPharmaceuticals (Basel)
December 2024
Department of Environmental Health Science, Institute of Natural Science and Agriculture, Konkuk University, Seoul 05029, Republic of Korea.
Nanotechnology has revolutionised biomedical research, offering innovative healthcare solutions. Plant-based nanotechnology is emerging as a sustainable alternative, minimising environmental impacts and enhancing therapeutic effectiveness. This paper explores the potential of plant-derived nanoparticles (PNPs) in medicine, highlighting their biocompatibility, multifunctionality, and eco-friendliness.
View Article and Find Full Text PDFMolecules
December 2024
NRC Institute of Immunology FMBA of Russia, 115552 Moscow, Russia.
N-Acetylgalactosamine (GalNAc) is an efficient and multifunctional delivery tool in the development and synthesis of chemically modified oligonucleotide therapeutics (conjugates). Such therapeutics demonstrate improved potency in vivo due to the selective and efficient delivery to hepatocytes in the liver via receptor-mediated endocytosis, which is what drives the high interest in this molecule. The ways to synthesize such structures are relatively new and have not been optimized in terms of the yields and stages both in lab and large-scale synthesis.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!